Assessment of CD37 B-cell antigen and cell of origin significantly improves risk prediction in diffuse large B-cell lymphoma
| dc.contributor.author | Xu-Monette, Zijun Y | |
| dc.contributor.author | Li, Ling | |
| dc.contributor.author | Byrd, John C | |
| dc.contributor.author | Jabbar, Kausar J | |
| dc.contributor.author | Manyam, Ganiraju C | |
| dc.contributor.author | de Winde, Charlotte Maria | |
| dc.contributor.author | van den Brand, Michiel | |
| dc.contributor.author | Tzankov, Alexandar | |
| dc.contributor.author | Visco, Carlo | |
| dc.contributor.author | Wang, Jing | |
| dc.contributor.author | Dybkaer, Karen | |
| dc.contributor.author | Chiu, April | |
| dc.contributor.author | Orazi, Attilio | |
| dc.contributor.author | Zu, Youli | |
| dc.contributor.author | Bhagat, Govind | |
| dc.contributor.author | Richards, Kristy L | |
| dc.contributor.author | Hsi, Eric D | |
| dc.contributor.author | Choi, William WL | |
| dc.contributor.author | Huh, Jooryung | |
| dc.contributor.author | Ponzoni, Maurilio | |
| dc.contributor.author | Ferreri, Andres JM | |
| dc.contributor.author | Moller, Michael B | |
| dc.contributor.author | Parsons, Ben M | |
| dc.contributor.author | Winter, Jane N | |
| dc.contributor.author | Wang, Michael | |
| dc.contributor.author | Hagemeister, Frederick B | |
| dc.contributor.author | Piris, Miguel A | |
| dc.contributor.author | van Krieken, J Han | |
| dc.contributor.author | Medeiros, L Jeffrey | |
| dc.contributor.author | Li, Yong | |
| dc.contributor.author | van Spriel, Annemiek B | |
| dc.contributor.author | Young, Ken H | |
| dc.date.accessioned | 2019-09-21T21:13:36Z | |
| dc.date.available | 2019-09-21T21:13:36Z | |
| dc.date.issued | 2016-12-29 | |
| dc.date.updated | 2019-09-21T21:13:35Z | |
| dc.identifier.issn | 0006-4971 | |
| dc.identifier.issn | 1528-0020 | |
| dc.identifier.uri | ||
| dc.language | English | |
| dc.publisher | AMER SOC HEMATOLOGY | |
| dc.relation.ispartof | BLOOD | |
| dc.relation.isversionof | 10.1182/blood-2016-05715094 | |
| dc.subject | Science & Technology | |
| dc.subject | Life Sciences & Biomedicine | |
| dc.subject | Hematology | |
| dc.subject | NON-HODGKINS-LYMPHOMA | |
| dc.subject | CLASS-II EXPRESSION | |
| dc.subject | PROGNOSTIC-SIGNIFICANCE | |
| dc.subject | THERAPEUTIC PROTEIN | |
| dc.subject | GENE-EXPRESSION | |
| dc.subject | POOR-PROGNOSIS | |
| dc.subject | CD20 LEVELS | |
| dc.subject | RITUXIMAB | |
| dc.subject | TETRASPANINS | |
| dc.subject | MECHANISMS | |
| dc.title | Assessment of CD37 B-cell antigen and cell of origin significantly improves risk prediction in diffuse large B-cell lymphoma | |
| dc.type | Journal article | |
| duke.contributor.orcid | Xu-Monette, Zijun Y|0000-0002-7615-3949 | |
| duke.contributor.orcid | Young, Ken H|0000-0002-5755-8932 | |
| pubs.begin-page | 3083 | |
| pubs.end-page | 3100 | |
| pubs.issue | 26 | |
| pubs.organisational-group | School of Medicine | |
| pubs.organisational-group | Duke | |
| pubs.organisational-group | Pathology | |
| pubs.organisational-group | Clinical Science Departments | |
| pubs.publication-status | Published | |
| pubs.volume | 128 |
Files
Original bundle
- Name:
- 121B, 2016 Blood, CD37 in DLBCL.pdf
- Size:
- 3.08 MB
- Format:
- Adobe Portable Document Format